Fieldpoint Private Securities, LLC Amicus Therapeutics, Inc. Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 10,241 shares of FOLD stock, worth $93,397. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,241
Previous 10,270
0.28%
Holding current value
$93,397
Previous $97,000
13.4%
% of portfolio
0.03%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$267 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$260 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$222 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$221 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$211 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.56B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...